ProShares UltraPro Russell 2000 Rating $69.90 -0.24 (-0.34%) Closing price 04:10 PM EasternExtended Trading$69.50 -0.40 (-0.58%) As of 08:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsNews and TrendsOwnershipRatingsSEC FilingsShort Interest ProShares UltraPro Russell 2000 Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.URTY Aggregate RatingModerate Buy 2.78Holdings in URTY have an aggregate rating of Moderate Buy based on 257 analyst ratings issued in the past year covering 17 companies (2.1% of the portfolio).URTY Aggregate Price Target$69.90High Prediction$69.90Average Prediction$69.90Low Prediction$69.90Holdings in URTY have an aggregate price target of $69.90 and a range of $69.90 to $69.90 covering 17 companies (2.1% of the portfolio).URTY Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy14 Moderate Buy rating(s)Hold1 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by ProShares UltraPro Russell 2000 Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 17 URTY Holdings ExportWeight In ETFCompanyShare PriceConsensus RatingConsensus Price TargetPossible UpsideNumber of RatingsMarketRank™Indicator(s)ViewRatings0.14%HUTHut 8$101.54-0.9%Buy$143.95 41.8%243.2441 of 5 starsTrending NewsAnalyst ForecastGap Down0.14%TWSTTwist Bioscience$184.03+16.1%Moderate Buy$103.00 -44.0%121.3105 of 5 starsTrending NewsAnalyst ForecastInsider TradeHigh Trading Volume0.13%UMBFUMB Financial$134.99+0.9%Moderate Buy$167.93 24.4%164.9468 of 5 stars0.13%VSATViasat$73.72+0.1%Moderate Buy$90.67 23.0%112.8679 of 5 starsTrending NewsInsider TradeGap Down0.13%FROGJFrog$94.20+2.0%Moderate Buy$109.48 16.2%233.0022 of 5 stars0.13%MOG.AMoog$382.57+2.0%Moderate Buy$462.33 20.8%43.568 of 5 starsNews Coverage0.12%GKOSGlaukos$154.74+0.8%Moderate Buy$180.54 16.7%152.902 of 5 starsNews CoverageAnalyst Forecast0.12%CTRECareTrust REIT$37.30+0.4%Moderate Buy$44.50 19.3%144.421 of 5 starsPositive News0.12%TXG10x Genomics$84.11+11.2%Hold$44.00 -47.7%171.5809 of 5 starsAnalyst ForecastInsider Trade0.12%BTSGBrightSpring Health Services$56.02+0.4%Buy$70.71 26.2%204.697 of 5 stars0.12%CYTKCytokinetics$65.66-0.2%Moderate Buy$103.37 57.4%202.7339 of 5 starsInsider Trade0.11%FCFSFirstCash$216.400.0%Moderate Buy$249.00 15.1%53.6388 of 5 stars0.11%KRYSKrystal Biotech$344.96+0.9%Moderate Buy$377.20 9.3%134.0311 of 5 starsPositive NewsAnalyst Forecast0.11%ONBOld National Bancorp$25.09+1.4%Moderate Buy$30.15 20.2%144.2253 of 5 starsAnalyst Forecast0.11%PTGXProtagonist Therapeutics$137.34-1.0%Moderate Buy$147.13 7.1%181.9539 of 5 starsPositive News0.11%EATBrinker International$206.77-1.9%Moderate Buy$243.38 17.7%243.8567 of 5 starsAnalyst Forecast0.11%JXNJackson Financial$130.06+0.3%Moderate Buy$133.80 2.9%71.675 of 5 stars This page (NYSEARCA:URTY) was last updated on 9/24/2026 by MarketBeat.com Staff. From Our PartnersA letter from Shannon StansberryPorter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...Porter & Company | SponsoredShocking new footage just releasedGerardo Del Real is calling it the Third Convergence Event, a new catalyst hitting the uranium market that he ...Digest Publishing | SponsoredYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | SponsoredCODE RED: AI Meltdown Imminent?After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...Paradigm Press | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredNASA's ISS Replacement Could Go to This Tiny Space FirmNASA has commissioned SpaceX to decommission the $150 billion International Space Station, but the contract to...Behind the Markets | SponsoredHow to get a stake in Anthropic — before the IPOAnthropic, the maker of Claude AI, has reportedly filed for an IPO that could arrive as early as October. Its ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding ProShares UltraPro Russell 2000 Please log in to your account or sign up in order to add this asset to your watchlist. Share ProShares UltraPro Russell 2000 With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.